Objective: We report on two patients with pyridoxine-dependent seizure
s who illustrate the varied clinical presentation and management probl
ems of this syndrome. Subjects and interventions: The first patient (a
Saudi girl who showed the typical presentation) was born meconium-sta
ined and had seizures in the first day of life that were finally contr
olled in the third day, 2 minutes after intravenous administration of
50 mg pyridoxine. Before initiating pyridoxine, a burst-suppression pa
ttern dominated her EEG. The second (a Sudanese girl) had an atypical
presentation. Onset was relatively late with irritability, hyperacusis
and vomiting at the age of 3 days, followed by subtle seizures that c
ould easily be controlled with conventional anticonvulsants. The diagn
osis was established at 3 1/2 months following recurrent attacks of af
ebrile multifocal myoclonic jerks. Parenteral injection of 100 mg pyri
doxine (given under EEG) resulted in cessation of electroclinical seiz
ures. Both patients exhibited lethargy, hypotonia and/or apnoea immedi
ately after pyridoxine administration. Main Outcome Measures and Concl
usion: After 7 years follow-up the first patient had only mild delay i
n language development. The second child had normal development at 14
months. The two patients represent the first cases reported from Saudi
Arabia and the Middle East.